EMA and NICE Appraisal Processes for Cancer Drugs - Research Database, The University of York

By the same authors

Ustekinumab for Treating Moderately to Severely Active Crohn's Disease after Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Hodgson, R., Walton, M., Biswas, M., Mebrahtu, T. & Woolacott, N., 30 Nov 2017
Article in PharmacoEconomics
Methodological challenges identified for the evaluation of clinical effectiveness in the context of accelerated regulatory approval: an overview
Woolacott, N., Corbett, M., Jones-Diette, J. & Hodgson, R., 12 Jul 2017
Article in Journal of Clinical Epidemiology
Crizotinib for Untreated Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Morgan, P. J., Woolacott, N. F., Biswas, M., Mebrahtu, T., Harden, M. & Hodgson, R., 24 Mar 2017
Review article in PharmacoEconomics
The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal
Hettle, R., Corbett, M., Hinde, S., Hodgson, R., Jones-Diette, J., Woolacott, N. & Palmer, S., 1 Mar 2017
Article in Health technology assessment
A Review of Ruxolitinib for the Treatment of Myelofibrosis: A Critique of the Evidence
Wade, R. F., Hodgson, R., Biswas, M., Harden, M. & Woolacott, N. F., Feb 2017
Article in PharmacoEconomics

From the same journal

Striving for a societal perspective: a framework for economic evaluations when costs and effects fall on multiple sectors and decision-makers
Walker, S. M., Griffin, S., Asaria, M., Tsuchiya, A. & Sculpher, M. J., 16 May 2019
Article in Applied Health Economics and Health Policy
The Value of Further Research: The Added Value of Individual-Participant Level Data
Saramago, P., Espinoza, M. A., Sutton, A. J., Manca, A. & Claxton, K., 23 Jan 2019
Article in Applied Health Economics and Health Policy
Public's willingness to pay towards a medical device for detecting foot ulceration in people with diabetes
Yang, F., Gannon, B. & Weightman, A., 9 Jun 2018
Article in Applied Health Economics and Health Policy
How do economic evaluations inform health policy decisions for treatment and prevention in Canada and the United States?
Husereau, D., Culyer, A. J., Neumann, P. & Jacobs, P., Jun 2015
Article in Applied Health Economics and Health Policy

From the same journal

Applied Health Economics and Health Policy (Journal)
Rita Faria (Reviewer)
Jan 2018
Activity: Publication peer-review and editorial work › Journal peer review
Applied Health Economics and Health Policy (Journal)
Marta O Soares (Reviewer)
2011
Activity: Publication peer-review and editorial work › Journal peer review
Applied Health Economics and Health Policy (Journal)
Maria Karen Goddard (Editorial board member)
Jan 2001 → 2007
Activity: Publication peer-review and editorial work › Editorial board

EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties

Research output: Contribution to journal › Article

Full text download(s)

Dickson2018_Article_EMAAndNICEAppraisalProcessesFo
408 KB, PDF-document

Published copy (DOI)

10.1007/s40258-018-0393-7

Author(s)

Rumona Dickson
Angela Boland
Rui Duarte
Eleanor Kotas
Nerys Woolacott
Robert Hodgson
Rob Riemsma
Sabine Grimm
Bram L T Ramaekers
Manuela A Joore
Nasuh Büyükkaramikli
Eva Kaltenthaler
Matt Stevenson
Abdullah Pandor
Steve Edwards
Martin Hoyle
Jonathan Shepherd
Xavier Armoiry
Miriam Brazzelli

Department/unit(s)

Centre for Reviews and Dissemination

Publication details

Journal	Applied Health Economics and Health Policy
Date	E-pub ahead of print - 28 May 2018
Date	Published (current) - Aug 2018
Issue number	4
Volume	16
Number of pages	4
Pages (from-to)	429-432
Early online date	28/05/18
Original language	English

Bibliographical note

© The Author(s), 2018

Research areas

Letter

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations

York staff: edit these data